Medical Advocates
HIV/HCV Coinfection
 
Drugs/Alternative Therapies

Peginterferon
Peginterferon Alpha 2a
Peginterferon Alpha 2b
Interferon Alpha
Interferon Alpha/Ribavirin
Inteleukin-2
Ribavirin
Tacrolimus
 Antiretrovirals/HAART
Antituberculosis Drugs
Milk Thistle
HIV/HCV Main Page New/Newsworthy Home Page
Last Update:  November 01, 2008  
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
Interferon: General Reports
 

    Conference Reports, Abstracts, and Posters

 
CONFERENCE PDF POSTER
 Efficacy of Pegylated Interferon + Ribavirin Treatment in HIV/HCV-co-infected Patients
Receiving Abacavir + Lamivudine or Tenofovir + either Lamivudine or Emtricitabine as
Nucleoside Analogue Backbone
 J Mira, L Lopez-Cortes, P Barreiro, et al
(15th C CROI)
 PDF Poster     Abstract

Infection Rates in HIV/HCV and HCV Patients Treated with Interferon Are Similar and not
Related to Neutropenia
(13 CROI)
 Abstract
Interferon Alpha
 
      Journal Papers, Abstracts, and Commentaries
 
 
Virus Dynamics and Immune Responses During Treatment in Patients Coinfected With
Hepatitis C and HIV.
 Talal AH, Shata MT, Markatou M
 J Acquir Immune Defic Syndr. 2004 Feb 1
 Abstract
 
FULL-TEXT ARTICLE
Fast relapse and high drop out rate of 48 weeks daily interferon monotherapy in HIV-infected
patients with chronic hepatitis C.
 Bruno R, Sacchi P, Puoti M, et al.
BMC Infect Dis 2002 Aug 28;2(1):17
Paper
Interferon Alpha/Ribavirin
 

    Journal Papers, Abstracts, and Commentaries

 
Fulminant autoimmune hepatitis after successful interferon treatment in an HIV-HCV co-infected
patient.
 Coriat R, Podevin P.
 Int J STD AIDS. 2008 Mar;19(3):208-10.
Abstract
 
A WEEK IN REVIEW FEATURED REPORT
Severe weight loss in HIV / HCV-coinfected patients treated with interferon plus ribavirin:
incidence and risk factors.
 Bani-Sadr F, Lapidus N, Melchior JC, et al 
J Viral Hepat. 2008 Apr;15(4):255-60.
 Abstract
 
Rapid and early virological response to chronic Hepatitis C treatment with IFN {alpha}2b or
PEG-IFN & [alpha]2b plus ribavirin in HIV/HCV co-infected patients.
 Payan C, Pivert A, Morand P, et al
 Gut. 2007 Mar 15;
 Abstract
 
Predictive Value of Early Virologic Response in HIV/Hepatitis C Virus-Coinfected Patients
Treated With an Interferon-Based Regimen Plus Ribavirin.
 Laguno M, Larrousse M, Murillas J, et al
J Acquir Immune Defic Syndr. 2006 Nov 9;
 Abstract
 
Serious ophthalmic pathology compromising vision in HCV/HIV co-infected patients treated with
peginterferon alpha-2b and ribavirin.
 Farel C, Suzman DL, McLaughlin M, et al  
AIDS. 2004 Sep 3;18(13):1805-9.
Abstract
 
T-lymphocyte populations in hepatitis C and HIV co-infected patients treated with interferon-
alfa-2a and ribavirin.
 Neau D, Galperine T, Legrand E, et al
 HIV Med 2003 Apr;4(2):120-126
 Abstract

Pilot study of interferon alpha high-dose induction therapy in combination with ribavirin for chronic
hepatitis C in HIV-co-infected patients.
 Rockstroh JK, Mudar M, Lichterfeld M, et al.  
 AIDS 2002 Oct 18;16(15):2083-5
 Abstract

    Conference Reports, Abstracts, and Posters

 
Long-term outcomes after peg-IFN plus pibavirin in HIV/HCV-cirrhotic patients with hypersplenism undergoing
partial splenic embolization (PSE)
 A. Moreno, R. Bárcena, C. Quereda, et al
 (XVII International AIDS Conference)
 Abstract
 
Interferon-Alfa Exposure for the Treatment of Hepatitis C Could Impair Immune Recovery in HIV
Infected Patients Under Antiretroviral Therapy
 I. MAIDA, V. SORIANO,  et al 
(45 ICAAC)
Abstract
 
Efficacy of Interferon and Ribavirin Therapy in HIV/HCV Co-infected Patients: Sustained Viral
Response Is Associated with a Rise in CD4 Lymphocyte Count
 A Urielrriero, J Lucas, et al.
(11 CROI)
 Abstract

Treatment of Chronic Hepatitis C: SHIRT (Spanish HIV Interferon Ribavirin Trial)
M. Pérez-Olmeda, V. Asensi, M. Romero,
(9RETRO)
 Abstract

  
Interleukin-2
 
    Journal Papers, Abstracts, and Commentaries
 
  Effect of IL-2 on hepatitis C virus RNA levels in patients co-infected with human
immunodeficiency virus receiving HAART.
 Tedaldi EM, Chen L, Markowitz N, et al 
J Viral Hepat. 2005 Jul;12(4):414-20.
 Abstract
   

     Conference Reports, Abstracts, and Posters
 
 
Effects of IL-2 on Hepatitis C Virus (HCV) Replication on HIV/HCV Co-Infected Patients
M. SANCHEZ-CONDE, P. CATALAN, J. COSIN, et al 
(45 ICAAC)
Abstract

POSTER
 Pilot Study of Low Dose Daily Interleukin-2 Plus Pegylated-Interferon-alfa-2b and Ribavirin in
Patients with HCV/HIV Co-infection: ACTG A5088
MJ Glesby, R Bassett, B Alston, et al
 (11 CROI)
 PDF Poster      Abstract
Ribavirin
 
     Journal Papers, Abstracts, and Commentaries
 
 
Early monitoring of ribavirin serum concentration is not useful to optimize hepatitis C virus
treatment in HIV-coinfected patients.
 Crespo M, Pou L, Esteban JI, et al 
Antivir Ther. 2007;12(8):1217-23.
 Abstract
 
Effect of ribavirin on intracellular and plasma pharmacokinetics of nucleoside reverse
transcriptase inhibitors in patients with human immunodeficiency virus-hepatitis C virus
coinfection: results of a randomized clinical study.
 Rodriguez-Torres M, Torriani FJ, Soriano V, et al
Antimicrob Agents Chemother. 2005 Oct;49(10):3997-4008.
 Abstract
 
Early Monitoring of Ribavirin Plasma Concentrations May Predict Anemia and
Early Virologic Response in HIV/Hepatitis C Virus-Coinfected Patients.
 Rendon AL, Nunez M, Romero M, et al
J Acquir Immune Defic Syndr. 2005 Aug 1;39(4):401-405.
Abstract
 

     Conference Reports, Abstracts, and Posters
 
 
Renal toxicity in HIV/Hepatitis C co-infected individuals exposed to tenofovir and/or Ribavarin
Jones R., Bower M., Mandalia S., et al
(XVI  International AIDS Conference)
Abstract

Ribavirin Plasma Concentrations throughout Hepatitis C Treatment Play a Major Role in the
Achievement of Sustained Virological Response in HIV/HCV Co-Infected Patients 
A. RENDÓN, M. NUÑEZ, M. ROMERO, et al
 (45 ICAAC)
Abstract
Tacrolimus
 
     Journal Papers, Abstracts, and Commentaries
 
 
Effect of Highly Active Antiretroviral Therapy on Tacrolimus Pharmacokinetics in Hepatitis
C Virus and HIV Co-Infected Liver Transplant Recipients in the ANRS HC-08 Study.
Teicher E, Vincent I, Bonhomme-Faivre L, et al
Clin Pharmacokinet. 2007;46(11):941-52.
 Abstract
Antituberculosis Drugs
 
     Journal Papers, Abstracts, and Commentaries
 
 
Changes in Hepatitis C Virus (HCV) Viral Load and Interferon-alpha Levels in HIV/HCV-Coinfected
Patients Treated With Highly Active Antiretroviral Therapy.
 Bower WA, Culver DH, Castor D, et al
 J Acquir Immune Defic Syndr. 2006 Jun 4;
 Abstract

Hepatitis B or hepatitis C co-infection in individuals infected with human immunodeficiency
virus and effect of anti-tuberculosis drugs on liver function.
 Padmapriyadarsini C, Chandrabose J, Victor L, 
J Postgrad Med. 2006 Apr-Jun;52(2):92-6.
Abstract
Milk Thistle
 
     Conference Reports, Abstracts, and Posters
 
 
Pilot trial of milk thistle in HIV/hepatitis C co-infection
 G. Carter , J. Godbold  , R. MacKay
(XVII International AIDS Conference)
 Abstract

 

HIV/HCV Main Page New/Newsworthy Home Page

HIV/HCV Drugs